BARCELONA, June 14 (Reuters) - UCB SA's experimental arthritis treatment Cimzia could be priced at a discount to rivals, since the drug has lower production costs, a key scientific investigator on the ...
LONDON (Reuters) - Cimzia stops structural damage to joints in patients with rheumatoid arthritis as soon as 16 weeks after the start of treatment, according to new data presented on Thursday. The ...
REYKJAVIK, ICELAND and LONDON, UK (July 1, 2025) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback